Nolfi-Donegan D, Annarapu G, St Croix C, Calderon M, Hillery C, Shiva S
JCI Insight. 2024; 9(5).
PMID: 38456510
PMC: 10972595.
DOI: 10.1172/jci.insight.174575.
Tucker B, Vaidya K, Cochran B, Patel S
Cells. 2021; 10(6).
PMID: 34199975
PMC: 8230292.
DOI: 10.3390/cells10061391.
Lebas H, Yahiaoui K, Martos R, Boulaftali Y
Front Cardiovasc Med. 2019; 6:132.
PMID: 31572732
PMC: 6749018.
DOI: 10.3389/fcvm.2019.00132.
Mani P, Puri R, Schwartz G, Nissen S, Shao M, Kastelein J
JAMA Cardiol. 2019; 4(4):314-320.
PMID: 30840024
PMC: 6484785.
DOI: 10.1001/jamacardio.2019.0179.
Salimi S, Lewis J, Yerges-Armstrong L, Mitchell B, Saeed F, OConnell J
J Am Heart Assoc. 2016; 5(11).
PMID: 27799230
PMC: 5210318.
DOI: 10.1161/JAHA.116.003751.
Prasugrel Results in Higher Decrease in High-Sensitivity C-Reactive Protein Level in Patients Undergoing Percutaneous Coronary Intervention Comparing to Clopidogrel.
Hajsadeghi S, Chitsazan M, Chitsazan M, Salehi N, Amin A, Bidokhti A
Clin Med Insights Cardiol. 2016; 10:149-55.
PMID: 27597810
PMC: 5006637.
DOI: 10.4137/CMC.S32804.
Changes of High Sensitivity C-Reactive Protein During Clopidogrel Therapy in Patients Undergoing Percutaneous Coronary Intervention.
Hajsadeghi S, Chitsazan M, Chitsazan M, Salehi N, Amin A, Maleki M
Res Cardiovasc Med. 2016; 5(1):e28997.
PMID: 26889454
PMC: 4749892.
DOI: 10.5812/cardiovascmed.28997.
Effects of P2Y12 receptor antagonists beyond platelet inhibition--comparison of ticagrelor with thienopyridines.
Nylander S, Schulz R
Br J Pharmacol. 2016; 173(7):1163-78.
PMID: 26758983
PMC: 5341337.
DOI: 10.1111/bph.13429.
Effects of clopidogrel therapy on oxidative stress, inflammation, vascular function, and progenitor cells in stable coronary artery disease.
Ramadan R, Dhawan S, Syed H, Pohlel F, Binongo J, Ghazzal Z
J Cardiovasc Pharmacol. 2013; 63(4):369-74.
PMID: 24336012
PMC: 4046585.
DOI: 10.1097/FJC.0000000000000057.
PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin.
Willerson J, Cable G, Yeh E
Tex Heart Inst J. 2010; 36(6):530-9.
PMID: 20069077
PMC: 2801957.
Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent): a multicenter, open-label study.
Wykrzykowska J, Warnholtz A, De Jaeger P, Curzen N, Oldroyd K, Collet J
J Thromb Thrombolysis. 2009; 28(4):410-7.
PMID: 19504052
PMC: 2766044.
DOI: 10.1007/s11239-009-0354-y.
Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel.
Motovska Z, Widimsky P
Vasc Health Risk Manag. 2009; 5(1):475-81.
PMID: 19475783
PMC: 2686264.
DOI: 10.2147/vhrm.s3969.
Efficacy of clopidrogel on reperfusion and high-sensitivity C-reactive protein in patients with acute myocardial infarction.
Akbulut M, Kutlu M, Ozbay Y, Polat V, Bilen M, Baydas A
Mediators Inflamm. 2009; 2009:932515.
PMID: 19365587
PMC: 2667940.
DOI: 10.1155/2009/932515.
Beyond platelet inhibition: potential pleiotropic effects of ADP-receptor antagonists.
Iyengar S, Rabbani L
J Thromb Thrombolysis. 2008; 27(3):300-6.
PMID: 18398577
DOI: 10.1007/s11239-008-0221-2.
Anti-inflammatory renoprotective effect of clopidogrel and irbesartan in chronic renal injury.
Tu X, Chen X, Xie Y, Shi S, Wang J, Chen Y
J Am Soc Nephrol. 2007; 19(1):77-83.
PMID: 18045851
PMC: 2391039.
DOI: 10.1681/ASN.2007020160.
Determining the efficacy of antiplatelet therapies for the individual: lessons from clinical trials.
Steinhubl S, Schneider D, Berger P, Becker R
J Thromb Thrombolysis. 2007; 26(1):8-13.
PMID: 17973080
DOI: 10.1007/s11239-007-0160-3.
Clopidogrel: a review of its use in the prevention of thrombosis.
Plosker G, Lyseng-Williamson K
Drugs. 2007; 67(4):613-46.
PMID: 17352522
DOI: 10.2165/00003495-200767040-00013.
Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease.
Osman R, LAllier P, Elgharib N, Tardif J
Vasc Health Risk Manag. 2007; 2(3):221-37.
PMID: 17326329
PMC: 1993979.
DOI: 10.2147/vhrm.2006.2.3.221.